Thailand selected to host IDF World Diabetes Congress 2025

# tags: Thailand , Events , Congress

Bangkok will host the congress.

Thailand is chosen to host "IDF World Diabetes Congress 2025". It is the first time that the congress heads to Southeast Asia region, reinforcing Thailand’s strategy towards becoming a global medical hub. The Congress in 2025 is forecast to attract 10,000 participants from around the world.

Mr. Chiruit Isarangkun Na Ayuthaya, president of Thailand Convention and Exhibition Bureau (TCEB), revealed that TCEB, in collaboration with the Diabetes Association of Thailand under the royal patronage of HRH Princess Maha Chakri Sirindhorn, has submitted a bid for the right to host the IDF World Diabetes Congress, one of the world’s largest international conferences on diabetes, to be held in Thailand. “This is a great opportunity for Thailand to host a world-class medical conference on diabetes. It also gives the Thai government and private sectors as well as stakeholders a platform to cooperate as host and support the organization of the IDF World Diabetes Congress 2025 (IDF 2025) which will take place between April 7-10, 2025, at the Bangkok International Trade and Exhibition Center (BITEC),” he said.

Prof. Akhtar Hussain, president of the International Diabetes Federation (IDF), said that the IDF World Diabetes Congress’s objectives include providing an ideal forum for the global diabetes community to continue to make the case for the level of attention, recognition, and resources that diabetes deserves. The congress will also help foster the collaborations, connections and political actions required to place diabetes at the top of the global health agenda and improve the lives of people living with diabetes and those at risk. The IDF is delighted to bring the IDF World Diabetes Congress to Bangkok.

The IDF World Diabetes Congress is held every two years in member country/territory and rotates across continents around the world. Participants include diabetes doctors, nurses, nutritionists, healthcare professionals, representatives from government agencies involved in public health policymaking and healthcare systems as well as diabetic patients.